Multivariate Cox proportional hazards models for all-cause death or HF hospitalization, all-cause death, and HF hospitalization
. | No. of events (%) . | Age- and sex-adjusted HR (95% CI) . | P-value . | Adjusted* HR (95% CI) . | P-value . |
---|---|---|---|---|---|
All-cause death or HF Hospitalization | |||||
Eplerenone | 95 (15%) | 0.86 (0.70–1.06) | 0.17 | 1.02 (0.82–1.27) | 0.86 |
Spironolactone | 1263 (18%) | 1.00 (ref.) | 1.00 (ref.) | ||
All-cause death | |||||
Eplerenone | 38 (6%) | 0.87 (0.62–1.21) | 0.41 | 0.93 (0.67–1.30) | 0.68 |
Spironolactone | 579 (8%) | 1.00 (ref.) | 1.00 (ref.) | ||
HF hospitalization | |||||
Eplerenone | 66 (10%) | 0.87 (0.68–1.13) | 0.30 | 1.10 (0.84–1.42) | 0.50 |
Spironolactone | 802 (12%) | 1.00 (ref.) | 1.00 (ref.) |
. | No. of events (%) . | Age- and sex-adjusted HR (95% CI) . | P-value . | Adjusted* HR (95% CI) . | P-value . |
---|---|---|---|---|---|
All-cause death or HF Hospitalization | |||||
Eplerenone | 95 (15%) | 0.86 (0.70–1.06) | 0.17 | 1.02 (0.82–1.27) | 0.86 |
Spironolactone | 1263 (18%) | 1.00 (ref.) | 1.00 (ref.) | ||
All-cause death | |||||
Eplerenone | 38 (6%) | 0.87 (0.62–1.21) | 0.41 | 0.93 (0.67–1.30) | 0.68 |
Spironolactone | 579 (8%) | 1.00 (ref.) | 1.00 (ref.) | ||
HF hospitalization | |||||
Eplerenone | 66 (10%) | 0.87 (0.68–1.13) | 0.30 | 1.10 (0.84–1.42) | 0.50 |
Spironolactone | 802 (12%) | 1.00 (ref.) | 1.00 (ref.) |
Multivariate Cox proportional hazards models for all-cause death or HF hospitalization, all-cause death, and HF hospitalization
. | No. of events (%) . | Age- and sex-adjusted HR (95% CI) . | P-value . | Adjusted* HR (95% CI) . | P-value . |
---|---|---|---|---|---|
All-cause death or HF Hospitalization | |||||
Eplerenone | 95 (15%) | 0.86 (0.70–1.06) | 0.17 | 1.02 (0.82–1.27) | 0.86 |
Spironolactone | 1263 (18%) | 1.00 (ref.) | 1.00 (ref.) | ||
All-cause death | |||||
Eplerenone | 38 (6%) | 0.87 (0.62–1.21) | 0.41 | 0.93 (0.67–1.30) | 0.68 |
Spironolactone | 579 (8%) | 1.00 (ref.) | 1.00 (ref.) | ||
HF hospitalization | |||||
Eplerenone | 66 (10%) | 0.87 (0.68–1.13) | 0.30 | 1.10 (0.84–1.42) | 0.50 |
Spironolactone | 802 (12%) | 1.00 (ref.) | 1.00 (ref.) |
. | No. of events (%) . | Age- and sex-adjusted HR (95% CI) . | P-value . | Adjusted* HR (95% CI) . | P-value . |
---|---|---|---|---|---|
All-cause death or HF Hospitalization | |||||
Eplerenone | 95 (15%) | 0.86 (0.70–1.06) | 0.17 | 1.02 (0.82–1.27) | 0.86 |
Spironolactone | 1263 (18%) | 1.00 (ref.) | 1.00 (ref.) | ||
All-cause death | |||||
Eplerenone | 38 (6%) | 0.87 (0.62–1.21) | 0.41 | 0.93 (0.67–1.30) | 0.68 |
Spironolactone | 579 (8%) | 1.00 (ref.) | 1.00 (ref.) | ||
HF hospitalization | |||||
Eplerenone | 66 (10%) | 0.87 (0.68–1.13) | 0.30 | 1.10 (0.84–1.42) | 0.50 |
Spironolactone | 802 (12%) | 1.00 (ref.) | 1.00 (ref.) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.